Company research / CDXS

Codexis, Inc. (CDXS)

SEC name CODEXIS, INC. · CIK 0001200375 · Nasdaq · Industrial Organic Chemicals

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Codexis, Inc. reported revenue of $70.39M. Revenue grew 18.6% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $77.68M.

Key ratios (year ended 2025-12-31)

86.7%
Gross margin (computed)
-59.3%
Operating margin
-62.5%
Net margin
-87.0%
Return on year-end equity
18.6%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-14

Headquarters locality: Redwood City · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$77.68M$70.39M$59.34M$70.14M$138.59M$104.75M$69.06M$68.46M$60.59M$50.02M$48.84M
Cost of Revenue$10.08M$9.34M$16.29M$12.81M$38.03M$22.21M$13.74M$15.63M$12.62M$14.33M$9.75M
Gross Profit (computed)$67.59M$61.05M$43.06M$57.33M$100.56M$82.55M$55.31M$52.83M$47.97M$35.70M$39.08M
R&D Expense$48.74M$52.31M$46.26M$58.88M$80.10M$55.92M$44.19M$33.87M$29.98M$29.66M$22.23M
Operating Income-$27.66M-$41.74M-$58.52M-$68.07M-$34.88M-$22.70M-$23.92M-$12.55M-$11.29M-$22.97M-$8.56M
Depreciation & Amortization$5.21M$5.25M$4.95M$5.52M$5.40Mn/an/an/an/an/an/a
EBITDA-$22.45M-$36.49M-$53.57M-$62.55M-$29.48Mn/an/an/an/an/an/a
Net Income-$30.72M-$43.97M-$65.28M-$76.24M-$33.59M-$21.28M-$24.01M-$11.94M-$10.88M-$23.00M-$8.56M
EPS (Diluted)n/a-$0.50-$0.89-$1.12-$0.51-$0.33-$0.40-$0.21n/an/an/a
Total Assets$120.06M$147.80M$149.01M$136.56M$250.39M$246.38M$221.65M$149.07M$79.28M$53.62M$35.65M
Total Liabilities$87.10M$97.27M$82.08M$49.95M$105.60M$81.99M$51.54M$43.56M$22.98M$29.08M$16.55M
Long-Term Debt$40.88M$40.10M$28.91Mn/an/an/an/an/an/an/an/a
Shareholders' Equity$32.96M$50.53M$66.93M$86.61M$144.80M$164.39M$170.10M$105.52M$56.31M$24.55M$19.10M
Cash & Equivalents$27.17M$50.79M$19.26M$65.12M$113.98M$116.80M$149.12M$90.50M$53.04M$31.22M$19.24M
Operating Cash Flow-$10.40M-$19.38M-$49.41M-$52.64M$11.28M-$14.27M-$16.46M-$12.56M-$14.09M-$8.76M-$1.86M
Capital Expenditures$1.78M$4.47M$4.30M$4.42M$8.31M$13.83M$3.75M$3.73M$2.77M$985.0K$888.0K
Free Cash Flow-$12.18M-$23.85M-$53.72M-$57.06M$2.98M-$28.09M-$20.21M-$16.29M-$16.86M-$9.74M-$2.75M
Shares Outstanding91.39M90.48M81.85M69.91M65.81M65.11M64.28M58.88M54.06M48.37M41.26M
Weighted Average Diluted Sharesn/a87.14M73.41M68.13M65.34M64.57M59.36M56.52Mn/an/an/a
EPS (Basic)n/a-$0.50-$0.89-$1.12-$0.51-$0.33-$0.40-$0.21n/an/an/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView